Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 3406230, 16 pages
https://doi.org/10.1155/2017/3406230
Review Article

HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined

Terasaki Foundation Laboratory, Los Angeles, CA, USA

Correspondence should be addressed to Nadim El-Awar; gro.balikasaret@rawalen

Received 21 December 2016; Accepted 14 February 2017; Published 24 May 2017

Academic Editor: Senthami R. Selvan

Copyright © 2017 Nadim El-Awar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. I. Terasaki, “Humoral theory of transplantation,” American Journal of Transplantation, vol. 3, no. 6, pp. 665–673, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. N. El-Awar, P. Terasaki, V. Lazda, A. Nikaein, C. Manning, and A. N. Arnold, “Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies,” Transplantation Proceedings, vol. 34, no. 7, pp. 2531-2532, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Pei, J. H. Lee, N. J. Shih, M. Chen, and P. I. Terasaki, “Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities,” Transplantation, vol. 75, no. 1, pp. 43–49, 2003. View at Publisher · View at Google Scholar
  4. J. Colombani, M. Colombani, and J. Dusset, “Cross-reactions in the HLA-system with special reference to Da6 cross-reacting group,” in Histocompatibility Testing, P. I. Terasaki, Ed., pp. 79–92, Munksgaard, Los Angeles, 1970. View at Google Scholar
  5. A. A. Fuller, J. E. Trevithick, G. E. Rodey, P. Parham, and T. C. Fuller, “Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes,” Human Immunology, vol. 28, no. 3, pp. 284–305, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Konoeda, P. I. Terasaki, A. Wakisaka, M. S. Park, and M. R. Mickey, “Public determinants of HLA indicated by pregnancy antibodies,” Transplantation, vol. 41, no. 2, pp. 253–259, 1986. View at Publisher · View at Google Scholar
  7. K. K. Mittal and P. I. Terasaki, “Cross-reactivity in the HL-A system,” Tissue Antigens, vol. 2, no. 2, pp. 94–104, 1972. View at Google Scholar
  8. G. E. Rodey, J. F. Neylan, J. D. Whelchel, K. W. Revels, and R. A. Bray, “Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients,” Human Immunology, vol. 39, no. 4, pp. 272–280, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Svejgaard and F. Kissmeyer-Nielsen, “Cross-reactive human HL-A isoantibodies,” Nature, vol. 219, no. 5156, pp. 868-869, 1968. View at Publisher · View at Google Scholar · View at Scopus
  10. J. J. Van Rood and A. Van Leeuwen, “Leukocyte grouping. A method and its application,” The Journal of Clinical Investigation, vol. 42, no. 9, pp. 1382–1390, 1963. View at Publisher · View at Google Scholar
  11. R. J. Duquesnoy, “Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?” Transfusion, vol. 48, no. 2, pp. 221–227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. J. Bjorkman, M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley, “Structure of the human class I histocompatibility antigen, HLA-A2,” Nature, vol. 329, no. 6139, pp. 506–512, 1987. View at Publisher · View at Google Scholar
  13. T. Akaza, N. El-Awar, A. Nguyen, J. Kitawaki, and T. Pl, “HLA class I epitopes: C-locus,” Clinical Transplants, pp. 95–102, 2006. View at Google Scholar
  14. N. El-Awar, J. H. Lee, C. Tarsitani, and P. I. Terasaki, “HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens,” Human Immunology, vol. 68, no. 3, pp. 170–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. N. El-Awar, P. I. Terasaki, J. Cai, C. T. Deng, M. Ozawa, and A. Nguyen, “Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens,” Clinical Transplants, pp. 175–194, 2007. View at Google Scholar
  16. N. El-Awar, P. I. Terasaki, A. Nguyen et al., “Epitopes of HLA antibodies found in sera of normal healthy males and cord blood,” Clinical Transplants, pp. 199–214, 2008. View at Google Scholar
  17. N. El-Awar, P. I. Terasaki, A. Nguyen et al., “Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood,” Human Immunology, vol. 70, no. 10, pp. 844–853, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. R. El-Awar, T. Akaza, P. I. Terasaki, and A. Nguyen, “Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus,” Transplantation, vol. 84, no. 4, pp. 532–540, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. C. T. Deng, J. Cai, M. Ozawa, and N. El-Awar, “HLA class II DP epitopes,” Clinical Transplants, pp. 195–202, 2007. View at Google Scholar
  20. C. T. Deng, J. Cai, C. Tarsitani, N. El-Awar, N. Lachmann, and M. Ozawa, “HLA class II DQ epitopes,” Clinical Transplants, pp. 115–122, 2006. View at Google Scholar
  21. C. T. Deng, N. El-Awar, M. Ozawa, J. Cai, N. Lachmann, and P. I. Terasaki, “Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients,” Transplantation, vol. 86, no. 3, pp. 452–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. N. El-Awar, P. I. Terasaki, J. Cai et al., “Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens,” Clinical Transplants, pp. 295–321, 2009. View at Google Scholar
  23. “Anthony Nolan Research Institute web site,” May, 2003. http://www.anthonynolan.org.uk/HIG/data.html.
  24. A. G. Amit, R. A. Mariuzza, S. E. Phillips, and R. J. Poljak, “Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution,” Science, vol. 233, no. 4765, pp. 747–753, 1986. View at Publisher · View at Google Scholar
  25. S. Sheriff, E. W. Silverton, E. A. Padlan et al., “Three-dimensional structure of an antibody-antigen complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 22, pp. 8075–8079, 1987. View at Google Scholar
  26. L. E. Morales-Buenrostro, P. I. Terasaki, L. A. Marino-Vázquez, J. H. Lee, N. El-Awar, and J. Alberú, “"Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males,” Transplantation, vol. 86, no. 8, pp. 1111–1115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. A. Lopez de Castro, J. A. Barbosa, M. S. Krangel, P. A. Biro, and J. L. Strominger, “Structural analysis of the functional sites of class I HLA antigens,” Immunological Reviews, vol. 85, no. 1, pp. 149–168, 1985. View at Publisher · View at Google Scholar
  28. R. J. Duquesnoy, “Human leukocyte antigen epitope antigenicity and immunogenicity,” Current Opinion in Organ Transplantation, vol. 19, no. 4, pp. 428–435, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. A. A. Fuller, G. E. Rodey, P. Parham, and T. C. Fuller, “Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes,” Human Immunology, vol. 28, no. 3, pp. 306–325, 1990. View at Publisher · View at Google Scholar · View at Scopus
  30. L. K. Gaur, P. Antonelli, E. A. Clark, and J. A. Hansen, “Evolution of HLA class I epitopes defined by murine monoclonal antibodies: distribution in macaques,” Human Immunology, vol. 17, no. 4, pp. 406–415, 1986. View at Publisher · View at Google Scholar · View at Scopus
  31. J. E. Gumperz, V. Litwin, J. H. Phillips, L. L. Lanier, and P. Parham, “The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor,” The Journal of Experimental Medicine, vol. 181, no. 3, pp. 1133–1144, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Parham, “Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate,” Immunogenetics, vol. 18, no. 1, pp. 1–16, 1983. View at Publisher · View at Google Scholar · View at Scopus
  33. R. D. Salter and P. Parham, “Mutually exclusive public epitopes of HLA-A,B,C molecules,” Human Immunology, vol. 26, no. 2, pp. 85–89, 1989. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. Wan, P. Ennis, P. Parham, and N. Holmes, “The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes,” Journal of Immunology, vol. 137, no. 11, pp. 3671–3674, 1986. View at Google Scholar
  35. R. J. Duquesnoy, “Epitope-based human leukocyte antigen matching for transplantation,” Current Opinion in Organ Transplantation, vol. 19, no. 4, pp. 418-419, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. R. J. Duquesnoy, “HLA epitope based matching for transplantation,” Transplant Immunology, vol. 31, no. 1, pp. 1–6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Wiebe, D. Pochinco, T. D. Blydt-Hansen et al., “Class II HLA epitope matching-a strategy to minimize de novo donor-specific antibody development and improve outcomes,” American Journal of Transplantation, vol. 13, no. 12, pp. 3114–3122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. D. C. Walton, S. J. Hiho, L. S. Cantwell et al., “HLA matching at the eplet level protects against chronic lung allograft dysfunction,” American Journal of Transplantation, vol. 16, no. 9, pp. 2695–2703, 2016. View at Publisher · View at Google Scholar · View at Scopus